Biotech buybacks—good or bad?

被引：0

|

作者：

Tom Jacobs

机构：

来源：

Nature Biotechnology | 2006年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1207 / 1207

相关论文

共 50 条

[1] Biotech buybacks - good or bad?
Jacobs, Tom
NATURE BIOTECHNOLOGY, 2006, 24 (10) : 1207 - 1207
[2] JAPANESE BIOTECH - THE GOOD WITH THE BAD
KLAUSNER, A
BIO-TECHNOLOGY, 1987, 5 (05): : 431 - 431
[3] The biotech century begins with a boom - Then a bust - Good, bad, good, bad ... What's next?
Burrill, GS
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (06): : 42 - +
[4] Down with the bad, up with the good - A biotech firm develops a vaccine to raise good cholesterol levels
Maeder, T
SCIENTIFIC AMERICAN, 2002, 286 (02) : 32 - 33
[5] Bad press and biotech
Nature Biotechnology, 1999, 17 : 1143 - 1143
[6] Bad press and biotech
不详
NATURE BIOTECHNOLOGY, 1999, 17 (12) : 1143 - 1143
[7] Are Buybacks Good for Long-Term Shareholder Value? Evidence from Buybacks around the World
Manconi, Alberto
Peyer, Urs
Vermaelen, Theo
JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2019, 54 (05) : 1899 - 1935
[8] Autophagy Not good OR bad, but good AND bad
Altman, Brian J.
Rathmell, Jeffrey C.
AUTOPHAGY, 2009, 5 (04) : 569 - 570
[9] When biotech goes bad
Hodgson, John
NATURE BIOTECHNOLOGY, 2016, 34 (03) : 284 - 291
[10] When biotech goes bad
John Hodgson
Nature Biotechnology, 2016, 34 : 284 - 291

← 1 2 3 4 5 →